Company news
GH Research PLC news in 2024
GH Research PLC's news releases, calls and decks from 2024, newest first.
GH Research Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 13, 2024
GH Research Reports Second Quarter 2024 Financial Results and Provides Business Updates
September 2, 2024
GH Research Announces Appointment of Dr. Velichka “Villy” Valcheva to Chief Executive Officer
September 2, 2024
GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates
May 2, 2024
GH Research Reports Full Year 2023 Financial Results and Provides Business Updates
February 28, 2024
GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression
January 17, 2024
Decks in 2024
- Investor Presentation (November 2024)
Investor deck · 15 slides · Nov 14, 2024
- 37th ECNP Congress (September 2024)
Conference · 10 slides · Sep 20, 2024
- Investor Presentation (September 2024)
Investor deck · 34 slides · Sep 3, 2024
- Investor Presentation (May 2024)
Investor deck · 34 slides · May 3, 2024
- Investor Presentation (February 2024)
Investor deck · 34 slides · Feb 29, 2024
- Investor Presentation (January 2024)
Investor deck · 30 slides · Jan 5, 2024